Error: Could not add to watchlist. X

Bradmer Pharmaceuticals Inc

+ Watchlist
BMR/H:CN
Venture
0.02
CAD
0.01
33.33%
As of 14:37:27 ET on 08/20/2015.
Open
0.02
Day Range
0.01 - 0.02
Volume
553,316
Previous Close
0.02
52Wk Range
0.01 - 0.02
Open
0.02
Day Range
0.01 - 0.02
Volume
553,316
Previous Close
0.02
52Wk Range
0.01 - 0.02
Current P/E Ratio (TTM)
75.75
Earnings per Share (USD) (TTM)
0.00
Market Cap (k CAD)
393.195
Shares Outstanding (m)
19.660
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Bradmer Pharmaceuticals Inc. is a biotechnology company focused on development and commercialization of cancer therapies. The lead product candidate, Neuradiab, is a therapy against certain brain cancers.
ADDRESS
Wildeboer Dellelce Place
365 Bay Street Suite 800
Toronto, ON M5H 2V1
Canada
PHONE
1-416-361-6058
  • Alan Mark Ezrin
    Chairman/President/CEO
  • Paul J Van Damme
    Chief Financial Officer
Show More